I n his talk “Atrial Fibrillation: Risk Stratification, Anticoagulation, Future Development” at Hospital Medicine 2015, Zayd A. ... Dr. Eldadah summarized recommendations for thrombosis control. For patients with a mechanical heart valve, he said,
How to handle anticoagulants, steroid, cardiac, diabetic, and pulmonary drugs in surgical patients. ... Cohn. Urgent cases, for example, hip fracture patients, may have a little more time for reversing anticoagulation before surgery.
New-generation anticoagulants associated with bleeding after ACS in patients on antiplatelet therapy
Patients with severe cardiac, renal or liver insufficiency and those with high bleeding risk (including those requiring long-term oral anticoagulation) were excluded. ... He called for additional research to examine the use of newer anticoagulants in
mitral valve involvement (HR, 1.29) or if they received anticoagulant therapy (HR 1.31). ... Based on these results, it seems advisable to avoid anticoagulant therapy in patients with these other risk factors, the study authors concluded.
In patients with atrial fibrillation, the advantages of all 4 new oral anticoagulants over warfarin seem to outweigh the risks, a new meta-analysis found. ... This meta-analysis “support(s) the premise that compared with warfarin, new oral
Higher CHADS. 2. scores pointed to higher risk for adverse outcomes, including stroke, bleeding and death, in patients with atrial fibrillation receiving anticoagulation, according to a new study. ... However, they concluded that increasing CHADS. 2.
A significant bleeding complication was defined as a need for pocket exploration or blood transfusion, hematoma requiring pressure dressing or change in anticoagulation therapy, or prolonged hospitalization. ... 4.3%; P <.001) and those who got no
Switching to aspirin or clopidogrel does not provide the same protective benefit, and it is not appropriate to discontinue all anticoagulation. ... Following atrial fibrillation ablation, anticoagulation should continue for 2 to 3 months; thereafter,
All involved anticoagulation with oral vitamin K antagonists, with the exception of one study in which some patients received novel oral anticoagulants. ... ICH recurred in 8.7% of patients who were receiving anticoagulation and 7.8% of those who were not
Researchers wrote that because many distal thrombi appear to resolve without anticoagulants, detection and treatment of distal DVT may be unnecessary. ... However, current clinical practice guidelines recommend 3 months of anticoagulation for distal DVT.